Reference/Coenzyme

NAD+

Essential Cellular Coenzyme & Anti-Aging Therapy

Human clinical

research use only

NAD+ is a crucial coenzyme found in every cell, involved in energy generation and cellular maintenance that naturally declines with age. Supplementation may support cellular health, boost energy, enhance cognitive function, and promote longevity through multiple delivery methods.

Restores mitochondrial function and ATP synthesisEnhances glucose and fat metabolismImproves oxygen utilization and enduranceActivates DNA repair mechanisms

6 citations·2 with human data·Updated 10 Aug 2026

Overview

Direct delivery to bloodstream ensures maximum cellular availability for energy production via ATP synthesis, DNA repair through PARP activation, and sirtuin-mediated longevity pathways. Supports mitochondrial function and metabolic homeostasis.

Evidence profilederived from 6 references

Human clinical

Strongest design among the references on this page. Grade and effect size are separate facts and are never merged into one score.

Research indications

What the compound has been studied for, grouped by body system. Effect size is the reported magnitude where it was measured — not a recommendation.

Energy & Metabolism3

Cellular Energy Production

Restores NAD+ levels for optimal ATP synthesis

Large

Metabolic Optimization

Enhances glucose and fat metabolism

Large

Exercise Performance

Improves oxygen utilization and endurance

Moderate

Anti-Aging3

DNA Repair

Activates PARP enzymes for genomic stability

Moderate

Sirtuin Activation

Supports longevity pathways

Moderate

Cellular Senescence Reduction

May help clear senescent cells

Small

Neurological2

Cognitive Enhancement

Improves mental clarity and focus

Small

Neuroprotection

Supports neuronal health and function

Small

A large effect in a weak study and a small effect in a strong one are different things. Effect size is never evidence of use in people.

Quick factsreference only

Class: Coenzyme
Molecular weight: 663.43 Da
Half-life: ~2.5 h
Typical dose: IV: 250-1000mg; IM/SubQ: 100-500mg; Intranasal: 25-50mg; Oral precursors: 100-500mg NMN/NR
Frequency: IV: 1-2x weekly; IM/SubQ: 2-3x weekly; Intranasal: 1-2x daily; Oral: daily
Cycle length: 4-12 weeks; IV therapy requires medical supervision
Storage: Refrigerate at 2-8°C; protect from light

Molecular data

Type: Coenzyme
Molecular weight: 663.43 Da
Half-life: 150 min

Dosing reference

Doses reported in the literature and by suppliers. These are a record of what has been used in research — reference, never instruction.

Context	Route	Amount	Frequency
IV Infusion	Intravenous	250-1000mg	1-2x weekly
IM/SubQ	Intramuscular or Subcutaneous	100-500mg	2-3x weekly
Precursor supplementation	Oral capsule	100-500mg NMN or NR	Daily
Cognitive support	Intranasal	25-50mg	1-2x daily

Interactions

BPC-157

Enhanced cellular repair and energy production

synergistic

TB-500

Complementary tissue regeneration effects

synergistic

Tirzepatide

Supports metabolic pathways enhanced by GLP-1 agonists

compatible

Ipamorelin

Growth hormone pathways benefit from improved energy metabolism

synergistic

CJC-1295

Enhanced recovery and anti-aging effects

compatible

Alcohol

Alcohol significantly reduces NAD+ levels and effectiveness

avoid

Quality checklist

✓Clear, colorless solution (injectable)
✓Proper refrigeration at 2-8°C
✓Sterile injection technique
✓Third-party tested for purity
!Use reconstituted solution within 28 days
×Cloudy or discolored solution indicates contamination
×Room temperature storage degrades NAD+ rapidly

What to expect

Week 1-2Initial energy improvements and mental clarity

Week 3-4Enhanced physical performance and recovery

Week 5-8Sustained energy levels and improved sleep quality

Week 9-12Optimized metabolic function and cognitive benefits

Safety

Commonly reported2

Mild flushing during IV infusion
Temporary nausea

Stop and seek advice4

Severe injection site reactions or infection signs
Persistent nausea or gastrointestinal distress
Unusual fatigue or weakness
Allergic reactions (rash, swelling, breathing difficulty)

Contraindications3

IV administration requires medical supervision
Avoid alcohol during treatment
Maintain consistent dosing schedule

FAQ

Why does NAD+ need to be injected instead of taken as a pill?

While oral NAD+ precursors (NMN, NR) are available and better absorbed than direct NAD+, injectable forms achieve 100% bioavailability and immediate cellular uptake. IV NAD+ bypasses the digestive system entirely, making it ideal for rapid energy restoration and those wanting guaranteed delivery.

Can I take NAD+ if I drink alcohol regularly?

No. Alcohol significantly reduces NAD+ levels and severely reduces the therapy's effectiveness. You should avoid alcohol during NAD+ treatment. If you drink regularly, consider addressing that habit first for maximum therapeutic benefit.

How long do the energy benefits of NAD+ last?

With IV NAD+, energy improvements typically appear within 1-2 weeks initially. However, the benefits build over time—by weeks 9-12, you'll see optimized metabolic function and sustained energy. Oral precursors take longer (weeks 5-8+) but provide continuous support when taken daily.

Does NAD+ actually reduce aging, or just make you feel more energetic?

NAD+ addresses aging mechanisms directly by activating sirtuins (longevity enzymes) and supporting DNA repair via PARP activation. However, it's not a fountain of youth—it optimizes cellular maintenance. Combined with healthy habits, NAD+ may help with appearance and age-related decline, but results vary individually.

References

1
NAD+ and Sirtuins in Aging and Disease
Imai, S., Guarente, L. · Trends in Cell Biology · 2014
Seminal review establishing that NAD+ decline is central to aging, driving defects in sirtuin-mediated nuclear and mitochondrial functions and resulting in age-associated pathologies.
reviewPubMed 24786309 ↗
2
Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults
Martens, C.R., et al. · Nature Communications · 2018
Randomized crossover trial showing NR (1000 mg/day for 6 weeks) is well tolerated and effectively elevates NAD+ in healthy middle-aged and older adults, with preliminary evidence for reduced blood pressure and arterial stiffness.
human-rctPubMed 29599478 ↗
3
Nicotinamide Mononucleotide Increases Muscle Insulin Sensitivity in Prediabetic Women
Yoshino, M., et al. · Science · 2021
First human clinical trial showing NMN (250 mg/day for 10 weeks) increases skeletal muscle insulin signaling and sensitivity in overweight/obese postmenopausal women with prediabetes.
reviewPubMed 33888596 ↗
4
NAD+ Metabolism and Its Roles in Cellular Processes During Ageing
Covarrubias, A.J., et al. · Nature Reviews Molecular Cell Biology · 2021
Comprehensive review of NAD+ metabolism during aging, detailing how senescent cells drive NAD+ decline via CD38+ macrophage activation and outlining therapeutic restoration strategies.
reviewPubMed 33353981 ↗
5
Efficacy of Oral NMN Supplementation on Glucose and Lipid Metabolism: A Systematic Review with Meta-Analysis of RCTs
Zhong, O., et al. · Journal of Translational Medicine · 2024
Meta-analysis of 8 RCTs (342 adults) found NMN significantly elevates blood NAD+ levels, but short-term supplementation (250-2000 mg/d) did not show significant improvements in glucose control or lipid profile in the general population.
meta-analysisPubMed 39116016 ↗
6
A Randomized Placebo-Controlled Trial of Nicotinamide Riboside in Older Adults with Mild Cognitive Impairment
Orr, M.E., et al. · GeroScience · 2024
NR was well tolerated and significantly increased blood NAD+ concentrations in older adults with MCI. Global methylation analyses indicated modest NR-associated reduction in epigenetic age by PhenoAge and GrimAge clocks.
human-rctPubMed 37994989 ↗